Compounds > 1h-tetrazole
Page last updated: 2024-08-24

1h-tetrazole and Leishmaniasis, Cutaneous

1h-tetrazole has been researched along with Leishmaniasis, Cutaneous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernardino, AM; Canto Cavalheiro, MM; Cunha-Júnior, EF; Dos Santos, MS; Faiões, Vdos S; Torres-Santos, EC1

Other Studies

1 other study(ies) available for 1h-tetrazole and Leishmaniasis, Cutaneous

ArticleYear
The new pyrazolyltetrazole derivative MSN20 is effective via oral delivery against cutaneous leishmaniasis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Administration, Oral; Animals; Antiprotozoal Agents; Inhibitory Concentration 50; Leishmaniasis, Cutaneous; Mice; Pyrazoles; Structure-Activity Relationship; Tetrazoles

2014